Quality of life after initial watchful waiting compared to immediate treatment

According to another publication based on data from the Physicians’ Health Study, “Quality of life outcomes in men who underwent delayed treatment after initially waiting were not worse than in men who underwent immediate treatment.”

Long-term watchful waiting and quality of life outcomes (compared to immediate treatment)

A new study in the Journal of Urology reports data on a cohort of 125 patients enrolled in the Physicians’ Health Study (PHS) who elected to be managed with watchful waiting for a minimum of 1 year after their initial diagnosis and who were followed for an average (mean) of 7.3 years.

The fine art of the circular argument applied to management of prostate cancer

It will likely be evident to most well-informed prostate cancer patients, support group leaders, and advocates that a man with low-risk, early stage prostate cancer (“favorable histology”) is potentially a good candidate for prostate cancer surgery.

Health-related QOL after salvage HIFU for recurrent, localized prostate cancer

Men with locally recurrent prostate cancer after first-line external beam radiation therapy (EBRT) have historically had three options for second-line treatment: salvage radical prostatectomy, salvage cryoablation, and salvage brachytherapy.

Long-term QoL of men in the Scandinavian Prostate Cancer Group 4 clinical trial

In 1989 the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) started randomizing men with a clinically initiated diagnosis of localized prostate cancer to either watchful waiting or open radical prostatectomy as their primary treatment. A new paper has now addressed the long-term quality of life (QoL) of men in this study.

“Dignity therapy” at the end of life

Most readers of this blog will never have heard of “dignity therapy.” It isn’t even listed on Wikipedia — although perhaps it will be shortly.

Quality of life, quality of death, and “end of life care”

Here in the USA, while our legally elected representatives in Washington, DC, pontificate about “death panels” and try to score political points over which of our two major political parties is more likely to “ration Grandpa to death,” most of us do, in fact, appreciate that we are going to die (at some point) and [...]

The role of exercise in prostate cancer management

Prostate cancer patients in general, but most especially men receiving androgen deprivation therapy (ADT), experience symptoms  and side effects of treatment that make it difficult to maintain their independence and quality of life. A recent review states that exercise may offset many of the side effects of ADT as well as those of the cancer [...]

What’s hot at the AUA annual meeting (Saturday)?

So the highlight of the meeting today has been a series of lectures given at the meeting of the Society for Urologic Oncology that were (to a large extent) focused on issues related to health outcomes and prostate cancer.

Use of CAM among rural prostate cancer patients in one US state

There is significant use of a variety of forms of complementary and alternative forms of medicine (CAM) among patients with localized prostate cancer. A new study in the Journal of Community Health has explored the prevalence and predictors of such behavior in a rural community setting.

Quality of life at 12 months post-surgery for localized prostate cancer

There is an interesting new report in the Journal of Urology that addresses perceptions of and actual quality of life of a cohort of German patients for up to 12 months after they were treated with radical prostatectomy for clinically localized prostate cancer.

Prostate cancer, hormone therapy, and physical well-being

It will come as little surprise to regular readers of this blog that androgen deprivation therapy (ADT) is associated with effects on health-related quality of life. However, few studies have attempted to assess the impact of ADT on true “physical well-being.”

Long-term QOL outcomes 4 years after PBRT

In a poster today at the Genitourinary Cancers Symposium, data was presented on 4-year follow-up of quality of life (QOL) among men treated with conformal proton beam radiation therapy (PBRT).

Surgery, brachytherapy, HRQOL, and the SPIRIT trial

The Surgical Prostatectomy versus Interstitial Radiation Intervention Trial or SPIRIT was a Phase III, partially randomized clinical trial, conducted in the U.S.A. and Canada, and designed to compare radical prostatectomy (RP) and brachytherapy (BT) as first-line treatments for men with localized prostate cancer.

Diabetes and quality of life among men with prostate cancer

It has long been recognized that the combination of prostate cancer and diabetes tends to have a notable impact on the health-related quality of life (HRQoL) of male patients.

Follow

Get every new post delivered to your Inbox.

Join 269 other followers